Ireland: Private Equity In Ireland 2019

Last Updated: 23 August 2019
Article by Aidan Fahy and Brian McCloskey


1.1 What are the most common types of private equity transactions in your jurisdiction? What is the current state of the market for these transactions? Have you seen any changes in the types of private equity transactions being implemented in the last two to three years?

A broad range of private equity ("PE") transactions are carried out in Ireland, the most common including leveraged buyouts, refinancings, trade sales, bolt-on deals and secondary buyouts.

The volume of PE transactions increased in 2018. A noticeable trend over the last 12 months has been the increase in the number of secondary buyouts which historically had not been a common feature of the Irish PE landscape.

1.2 What are the most significant factors encouraging or inhibiting private equity transactions in your jurisdiction?

Ireland delivers:

  • a low corporate tax rate – corporation tax on trading profits is 12.5% and the regime does not breach EU or OECD harmful tax competition criteria;
  • the regulatory, economic and people infrastructure of a highly-developed OECD jurisdiction;
  • the benefits of EU membership and of being the only English-speaking jurisdiction in the eurozone;
  • a common law jurisdiction, with a legal system that is broadly similar to the US and the UK systems;
  • refundable tax credit for research and development activity and other incentives; and
  • an extensive and expanding double tax treaty network, which includes over 70 countries, including the US, UK, China and Japan.

1.3 What trends do you anticipate seeing in (i) the next 12 months and (ii) the longer term for private equity transactions in your jurisdiction?

Irish economic growth is expected to continue in 2019 – the Central Bank of Ireland has recently forecasted economic growth of more than 4% this year, which follows growth of more than 5% in 2018. This means that Irish businesses will remain attractive to both local and international PE investors. The competition between investors will likely lead to more flexibility from PE funds in terms of both the structure and terms of transactions, with minority investments becoming more common.


2.1 What are the most common acquisition structures adopted for private equity transactions in your jurisdiction?

PE transactions are usually structured using a holding company ("Holdco") and an indirect wholly-owned subsidiary of Holdco ("Bidco"). Holdco is commonly owned by the PE fund and management, as majority and minority shareholders, respectively. Holdco can take the form of an offshore vehicle, although it is usually Irish or UK tax resident.

Bidco's primary role is to acquire and hold the target's shares and it may also act as borrower under the debt facilities. For tax- and/or financing-related purposes, it is common to have intermediate holding companies inserted between Holdco and Bidco.

For inbound investments, Bidco is typically a private limited liability company resident, for tax purposes, in Ireland. The jurisdiction of incorporation of Bidco can vary and may be onshore or offshore.

2.2 What are the main drivers for these acquisition structures?

There are a number of factors which affect the acquisition structure adopted in PE transactions. These drivers include: (i) the tax requirements, capacity and sensitivities of the PE house, management and target; (ii) the finance providers' requirements; and (iii) the expected profile of investor returns.

2.3 How is the equity commonly structured in private equity transactions in your jurisdiction (including institutional, management and carried interests)?

PE investors typically use small proportions of equity finance to subscribe for ordinary or preferred ordinary shares in Holdco. The balance is generally invested as a shareholder loan (often structured as loan notes issued by Holdco), or preference shares.

Management will generally subscribe for ordinary shares in Holdco representing between 5% and 15%, commonly referred to as "sweet equity". On some buyouts, key senior management with sufficient funds to do so may also be permitted (and/or required) to invest in the institutional strip.

Senior management are usually expected to make sufficient financial investment in the target group to ensure their interests remain aligned with the PE investor and that they remain incentivised to create further value. They will also typically sign up to contractual restrictions (see question 2.5 below).

Other key personnel may be invited to participate in management incentive plans or to become additional employee shareholders.

2.4 If a private equity investor is taking a minority position, are there different structuring considerations?

Typically a PE investor taking a minority position will invest directly through an existing entity rather than investing through a newly established Irish special purpose vehicle. A minority PE investor will typically be more focused on veto rights, given it is unlikely to have board control. Depending on the size of the stake, vesting periods for management shares, good leaver/bad leaver provisions may be somewhat relaxed.

From a tax structuring perspective, the availability of Ireland's "substantial shareholders" exemption should be borne in mind in the context of minority investments, as this relief from Irish capital gains tax ("CGT") only applies where a minimum 5% shareholding has been held for a particular holding period. Further detail on the "substantial shareholders" exemption is contained at question 9.1 below.

2.5 In relation to management equity, what is the typical range of equity allocated to the management, and what are the typical vesting and compulsory acquisition provisions?

See question 2.3 for the typical range of equity allocated to the management.

Transaction documents will invariably include provisions enabling the PE fund to compulsorily acquire a manager's shares on termination of his/her employment with the relevant portfolio company.

Documentation will usually include good leaver/bad leaver provisions, which will determine the amount payable to the departing manager. See question 2.6 for further information on good leaver/bad leaver provisions.

A "good leaver" will commonly obtain the higher of cost and fair market value for his/her shares while a "bad leaver" may expect to receive the lower of fair market value and cost. The documentation may also contain clawback provisions whereby an individual who has been treated as a "good leaver" but subsequently breaches, for example, restrictive covenants or other material provisions of the relevant documentation, will be required to reimburse the "good leaver" portion of the proceeds received by him or her.

The relevant documentation may also include vesting provisions that will regulate the proportion of shares for which the departing employee will be entitled to the "good leaver" price (i.e. higher of cost and fair market value) by reference to the length of the period from buyout to termination. Vesting may be straight-line or stepped and full vesting may typically occur after a period of between three and five years.

2.6 For what reasons is a management equity holder usually treated as a good leaver or a bad leaver in your jurisdiction?

As the competition for suitable assets has increased in parallel with the general increase in PE activity in Ireland, an increasingly common approach taken by PE funds is to have more management friendly leaver provisions whereby a "bad leaver" is defined by reference to specific circumstances (voluntary resignation, termination for gross misconduct, etc.), with all other circumstances constituting a "good leaver".


3.1 What are the typical governance arrangements for private equity portfolio companies? Are such arrangements required to be made publicly available in your jurisdiction?

PE houses and management will typically enter into a shareholders' agreement to govern their relations as shareholders in the portfolio company. This will likely include, among other provisions: (i) covenants from management with regard to the conduct of the business of the portfolio company; (ii) extensive veto rights for the PE house; (iii) restrictions on the transfer of securities in the portfolio company; and (iv) provisions regarding further issuances of shareholder equity/debt.

In addition, the constitutional documents may include governance arrangements, particularly with regard to the transfer of shares and the appointment of directors.

3.2 Do private equity investors and/or their director nominees typically enjoy veto rights over major corporate actions (such as acquisitions and disposals, business plans, related party transactions, etc.)? If a private equity investor takes a minority position, what veto rights would they typically enjoy?

PE investors normally enjoy significant veto rights over major corporate, commercial and financial matters, although thresholds are commonly set to ensure that day-to-day decisions can be taken by management.

These veto rights will typically be split between director veto rights and shareholder veto rights.

In a minority PE investment, given the PE house is unlikely to have board control, the PE house is typically much more focused on veto controls and in particular around new equity/debt issues, budget control and acquisitions and disposals.

3.3 Are there any limitations on the effectiveness of veto arrangements: (i) at the shareholder level; and (ii) at the director nominee level? If so, how are these typically addressed?

Veto rights will generally be respected by Irish courts, but may be found to be void if they constitute an unlawful fetter on any statutory powers of an Irish company or are contrary to public policy. Generally, appropriate structures can be put in place to ensure that customary veto rights are effective.

A shareholders' agreement is likely to be entered into to ensure that agreed veto arrangements would be upheld at the shareholder level. Such an agreement may also oblige the shareholders to procure that certain actions are taken (or not taken) by the relevant target group companies.

Directors' veto rights need to be balanced with the directors' duty to act in the best interests of the portfolio company. Hence, it is wise to retain shareholder level veto rights.

3.4 Are there any duties owed by a private equity investor to minority shareholders such as management shareholders (or vice versa)? If so, how are these typically addressed?

The PE investor itself is not subject to fiduciary or other duties under Irish company law to the minority shareholders (but see question 3.6 below for potential liability as shadow director). Board nominees generally owe duties to the company, but may, in limited circumstances, owe duties to shareholders (for example, regarding information disclosure).

Certain duties may also be owed if: (i) the portfolio company is insolvent or verging on insolvency; or (ii) if a specific special relationship (for example, principal and agent) is established between the nominee directors and the shareholders.

Shareholders may be entitled to bring derivative actions on behalf of the company against the nominee directors (often as a last resort), although it may be difficult to establish the eligibility of the shareholders to bring such an action under company law.

3.5 Are there any limitations or restrictions on the contents or enforceability of shareholder agreements (including (i) governing law and jurisdiction, and (ii) non-compete and non-solicit provisions)?

Save to the extent that they contravene statute or are contrary to public policy, there are no such limitations or restrictions that would apply with respect to an Irish company as regards enforceability. However, if the group structure includes companies from other jurisdictions, the impact of the laws of those jurisdictions will need to be considered. Non-complete restrictions will only be enforced to the extent reasonable in terms of geographical, temporal and sectoral scope. Governing law clauses which set non-Irish law as the law of choice will typically be respected by the Irish Courts.

3.6 Are there any legal restrictions or other requirements that a private equity investor should be aware of in appointing its nominees to boards of portfolio companies? What are the key potential risks and liabilities for (i) directors nominated by private equity investors to portfolio company boards, and (ii) private equity investors that nominate directors to boards of portfolio companies?

PE investors must ensure that nominee directors are eligible to act as directors, including, in particular, that they are not disqualified by statute or restricted from so acting under Irish company law.

In the context of being entitled to nominate directors, PE investors ought to be aware that in certain circumstances they may be construed as "shadow directors" under s. 221 of the Companies Act 2014 ("CA"), if the nominee directors are accustomed to act according to the directions and instructions of the PE fund. If construed as shadow directors, the PE investor would be treated as a director of the portfolio company and directors' duties would apply to it.

Nominated directors risk incurring liabilities if they breach their directors' duties (including their statutory duties under ss. 223–228 CA) and may face the risk of clawback action for certain decisions made during certain periods of time if the company is insolvent or verging on insolvency.

PE investors will typically seek to mitigate the impact of the above risks through directors' and officers' insurance policies.

3.7 How do directors nominated by private equity investors deal with actual and potential conflicts of interest arising from (i) their relationship with the party nominating them, and (ii) positions as directors of other portfolio companies?

Such directors must be mindful that although they are nominee directors, their duties are generally owed to the company itself and not to the party nominating them or other shareholders.

The CA (s. 228(i)(f)) imposes a duty on a director to "avoid any conflict between the directors' duties and...other interests unless the director is released from his or her duty to the company...". Such an actual or potential conflict of interest may arise, for example, with respect to (i) the nominating PE house, or (ii) the directors' other directorial positions.

A specific release passed in a general meeting or included within the portfolio company's constitution in relation to any matter of concern would reduce this list.


4.1 What are the major issues impacting the timetable for transactions in your jurisdiction, including antitrust and other regulatory approval requirements, disclosure obligations and financing issues?

The timing for transactions is largely affected by regulatory approvals, mainly competition or other sector-specific approvals. For instance, a number of PE funds have invested in regulated financial services (including insurance) companies in the last 12 months which have been subject to the prior approval of the Central Bank of Ireland – see further question 10.2. The time required to prepare suitable financial statements (particularly given the prevalence of locked-box-pricing mechanisms in PE transactions) can also impact significantly on timing.

4.2 Have there been any discernible trends in transaction terms over recent years?

The M&A landscape remains generally favourable to PE sellers in Ireland. Recent trends include: (i) continuing prevalence of the "locked-box" consideration structure; (ii) increase in deals involving warranty and indemnity insurance; (iii) continuing limited representation and warranty protection from PE sellers; and (iv) reducing limitation of liability periods.


5.1 What particular features and/or challenges apply to private equity investors involved in public-to-private transactions (and their financing) and how are these commonly dealt with?

In public-to-private transactions involving Irish companies, the Irish Takeover Rules ("Takeover Rules") will usually apply. The Takeover Rules regulate the conduct of takeovers of, and certain other transactions affecting, Irish companies listed on certain stock exchanges, and contain detailed provisions covering matters such as confidentiality, announcement obligations, deal timetable, capped break fees and public disclosure. The Takeover Rules are administered by the Irish Takeover Panel (the "Panel"), which has supervisory jurisdiction over such transactions.

While the application of the Takeover Rules means that such transactions are generally subject to a more restrictive framework than a typical private company transaction, there are three particular Takeover Rules features of note:

  • A transaction must be independently cash-confirmed before a bidder can announce a firm intention to make an offer. For a PE investor, this means that, at the time of announcement, its funding will need to be unconditionally available to the bidder (including possibly being placed in escrow).
  • Once a firm's intention to make an offer is announced, a bidder will generally be bound to proceed with the offer. Furthermore, save for the acceptance condition or any competition/anti-trust condition, once an offer is made, the bidder will have limited scope to invoke any other condition to lapse or withdraw the offer. This increases the importance of due diligence for the PE investor.
  • Special arrangements with any category of target shareholder, including management incentivisation proposals, will generally require Panel consent. Such consent may be given subject to independent shareholder approval at a general meeting. This necessitates the importance of early formulation of such arrangements or proposals and engagement with the Panel.

5.2 What deal protections are available to private equity investors in your jurisdiction in relation to public acquisitions?

Break fees are allowed in relation to public acquisitions with Panel consent. The Panel will typically only consent to break-fee arrangements of up to 1% of the value of an offer, with limited trigger events, including: (i) the withdrawal of an offer recommendation by the target board resulting in the offer being withdrawn or lapsing; or (ii) the success of a competing offer. The mere failure to achieve a minimum acceptance level in the absence of (i) or (ii) would not typically be an acceptable trigger for payment of a break-fee.

The target can also agree not to shop the company or its assets, subject to consideration of the fiduciary duties of the directors.


6.1 What consideration structures are typically preferred by private equity investors (i) on the sell-side, and (ii) on the buy-side, in your jurisdiction?

"Locked-box" structures are generally preferred by PE sellers as they offer certainty in the purchase price from the outset, greater control over financial information, potentially reduced contractual liability, cost savings and prompt distribution of sale proceeds to investors/sellers after completion. The buyer will be compensated for any "leakage" of value from the target group following the "locked-box date" (save to the extent the parties agree such leakage is to be treated as "permitted" (and so not to form the basis of any adjustment)).

Other consideration structures commonly used may involve adjustments by reference to working capital and net debt. These structures rely on a statement or set of accounts drawn up shortly after completion and adjustments are made to the purchase price based on deviations from reference balance sheets/accounts, drawn up prior to execution of the share purchase agreement (and on which the pricing has, in theory, been based).

6.2 What is the typical package of warranties/indemnities offered by a private equity seller and its management team to a buyer?

A PE seller usually only provides warranties regarding title to its own shares, capacity and authority.

The target's management will often (subject to their percentage ownership and on the basis they are usually better placed to) provide business warranties, under a separate management warranty deed. The key rationale for the warranties is generally to elicit full disclosure regarding the target during the due diligence process, although the negotiated warranty package may form the basis for warranty and indemnity insurance protection.

6.3 What is the typical scope of other covenants, undertakings and indemnities provided by a private equity seller and its management team to a buyer?

A PE seller will usually provide pre-completion undertakings in relation to no-leakage (in a locked-box pricing structure) and assistance with regulatory filings and, in some cases, undertakings regarding the conduct of the target business pre-completion (although frequently limited to exercise of voting in a manner aimed at achieving such outcome rather than an absolute procure covenant).

A PE seller is very unlikely to provide non-compete covenants, but these may be provided by members of management who are exiting the target business. Typically non-solicitation of employees covenants will be acceptable to a PE seller.

Management will also generally provide pre-completion undertakings regarding the conduct of the target business pre-completion.

6.4 To what extent is representation & warranty insurance used in your jurisdiction? If so, what are the typical (i) excesses / policy limits, and (ii) carve-outs / exclusions from such insurance policies, and what is the typical cost of such insurance?

Buyer warranty and indemnity insurance policies are increasingly obtained and preliminary terms for buy-side insurance are commonly included by PE sellers as part of the initial sell-side transaction documentation, for buyer and insurer to agree during negotiation of the sale and purchase documentation.

These will typically be given on the basis of a set of business warranties given by management, but subject to limitations designed to ensure that personal liability of management is limited.

A policy will usually be subject to excess limits and sellers or management can often be asked to bridge some or all of that gap. Excess limits tend to be between 0.5% and 1% of the enterprise value of the target.

Some market standard exclusions applied by insurance providers include coverage for criminal fines and penalties, pollution/ contamination, fraud, dishonesty and deliberate non-disclosure of the policyholder.

Subject to minimum premium amounts, premiums tend to be broadly between 1% and 1.5% of the insured limit.

6.5 What limitations will typically apply to the liability of a private equity seller and management team under warranties, covenants, indemnities and undertakings?

On the basis that a PE seller's warranties will generally be limited to title, capacity and authority, a PE seller's warranties are usually either subject to a cap equal to the aggregate purchase price or uncapped.

Liability under any "no-leakage" covenant will likely be limited to a relatively small amount which is commonly escrowed.

Managers can limit their liability under the warranties by: (i) giving them severally (each manager is only liable for its proportionate share of liability for any claim and/or its own breach) and subject to awareness; and (ii) capping maximum liability for any warranty claims.

In a transaction including warranty and indemnity insurance, the cap on management liability for warranties will often be set at the level of the insurance deductible/excess.

General limitations include time limits within which claims may be brought, and de minimis and basket thresholds.

6.6 Do (i) private equity sellers provide security (e.g. escrow accounts) for any warranties / liabilities, and (ii) private equity buyers insist on any security for warranties / liabilities (including any obtained from the management team)?

Escrow retention accounts do feature in some transactions but PE sellers typically look to resist such arrangements. This is particularly true as the prevalence of W&I insurance on transactions increases. PE buyers will regularly look to have escrow accounts for management warranties but again, this trend is evolving in line with the increasingly flexible W&I insurance market.

6.7 How do private equity buyers typically provide comfort as to the availability of (i) debt finance, and (ii) equity finance? What rights of enforcement do sellers typically obtain in the absence of compliance by the buying entity (e.g. equity underwrite of debt funding, right to specific performance of obligations under an equity commitment letter, damages, etc.)?

The PE fund usually gives a direct commitment to the seller to fund Bidco with the equity capital committed to the transaction, subject only to the satisfaction of the conditions in the share purchase agreement and financing being available. The seller can generally enforce this commitment directly against the PE fund to the extent it becomes unconditional and the PE fund fails to fund Bidco.

6.8 Are reverse break fees prevalent in private equity transactions to limit private equity buyers' exposure? If so, what terms are typical?

Reverse break fees are unusual in PE transactions in Ireland.


7.1 What particular features and/or challenges should a private equity seller be aware of in considering an IPO exit?

Typically, an Irish IPO will be part of a dual-listing with either a UK or US listing. There are a number of key issues which need to be considered by PE sellers considering an IPO exit, including the following:

  • Market risk: unlike certain other PE exit routes, PE sellers are exposed to market risk when looking to access institutional investor capital through an IPO process. Sellers can look to mitigate this risk by commencing a pre-marketing campaign earlier in the deal timeline to try and secure a successful outcome (equally, however, this means that if there is a need to postpone the transaction for whatever reason, it can be seen as a more significant failure by the investor community).
  • Lock-ups/selling restrictions: PE sellers may not be able to dispose of their stake in the business completely at the time of the IPO. PE sellers may be subject to a lock-up period during which they would be unable to sell some, or all, of their stake in the business to prevent detrimental effects on the valuation of the company immediately after the IPO. As such, there would be a delay between the time of the IPO and the time at which the PE fund would fully realise its investment. Please see the response to question 7.2 for further commentary on the duration of lock-ups.
  • Contractual obligations relating to the IPO: the PE seller will be required to be a party to the underwriting agreement entered into with the investment banks underwriting the IPO. The PE seller will be expected to give a suite of representations and warranties to the banks as to a range of matters relating to itself and the shares it owns and, to a more limited extent, the company being floated and its business. It will also be expected to give the underwriting banks a broad transaction indemnity covering any losses they may incur in connection with the transaction.
  • Corporate governance: on the IPO, depending on the listing venue, companies are often required to adopt a particular corporate governance framework. Therefore, whilst the PE seller may have enjoyed contractual rights to board representation and other matters prior to the IPO, these are likely to be significantly constrained on completion of the IPO (please see further the response to question 7.3 below).

7.2 What customary lock-ups would be imposed on private equity sellers on an IPO exit?

The duration of the lock-up provided by the PE seller will vary from transaction to transaction, but is typically for a period of six months following the IPO. As a result, the PE seller will be exposed to market risk for the duration of the lock-up period in respect of any stock it retains, with no ability to sell if the market begins to turn or the company's performance declines.

7.3 Do private equity sellers generally pursue a dual-track exit process? If so, (i) how late in the process are private equity sellers continuing to run the dual-track, and (ii) were more dual-track deals ultimately realised through a sale or IPO?

Almost all Irish transactions in recent years have concluded through a sale rather than an IPO. Typically, a PE seller looking to exit by way of an IPO will look to an IPO by way of a dual-listing in Ireland and either the US or UK.


8.1 Please outline the most common sources of debt finance used to fund private equity transactions in your jurisdiction and provide an overview of the current state of the finance market in your jurisdiction for such debt (particularly the market for high yield bonds).

Traditional bank-led leveraged loan financing remains the most common source of debt finance used to fund both mid-market and large PE transactions in Ireland.

However, in recent years, there has been increasing competition between traditional bank lenders and non-bank (or "alternative") lenders and funds, which has resulted in a wide array of other debt products being offered to market participants to replace and/or supplement traditional senior secured bank loans. These include term loan B ("TLB") facilities, mezzanine and unitranche loans and second lien loan products. For certain transactions, some market participants have also been able to turn to direct lending funds.

8.2 Are there any relevant legal requirements or restrictions impacting the nature or structure of the debt financing (or any particular type of debt financing) of private equity transactions?

There are no particular legal requirements or restrictions that would affect the choice or structure of debt financing of PE transactions in Ireland generally. However, market participants should be aware of, and ensure compliance with, any industry specific laws and regulations, as well as the broader regulatory regime affecting PE transactions.

For example, market participants need to be especially careful in regards to compliance with anti-bribery, corruption and sanctions laws. Aside from local laws, borrowers and sponsors should also be aware of the expansive nature and potential extraterritorial reach of such laws and regulations in the US, which can necessitate compliance by many non-US entities (or entities that have only limited US ties).

8.3 What recent trends have there been in the debt financing market in your jurisdiction?

The availability of credit continued to increase in 2018, particularly for businesses engaged in commercial real estate. The source of this credit, however, has continued to shift away from traditional lenders to a mixture of banks, mezzanine lenders and non-bank lenders. After the financial crisis, increased regulatory pressure on banks as a whole to deleverage and reduce their loan books left a liquidity gap in the market, which non-bank lenders took advantage of.

The most significant effect on the Irish loan market will undoubtedly be Brexit. It is impossible to predict exactly how the loan market in Ireland will be affected by the planned exit of the UK from the EU.


9.1 What are the key tax considerations for private equity investors and transactions in your jurisdiction? Are off-shore structures common?

When investing in an Irish target, key tax considerations for PE investors will include the choice of holding structure, transaction tax costs, debt financing considerations, and the management of tax costs on the flows of cash from the portfolio companies.

In terms of Ireland as a holding company jurisdiction, Ireland offers an attractive tax regime for holding companies. Irish holding companies can receive dividends from their Irish subsidiaries tax-free and from foreign subsidiaries on an effective Irish tax-free basis (or with a very low effective rate of Irish tax). This is due to a combination of Ireland's low corporation tax rate and the availability of Irish credit relief for foreign taxes.

Ireland's "substantial shareholders" exemption relieves Irish holding companies from Irish CGT on the disposals of subsidiaries. Two main conditions apply: (a) the subsidiaries must be resident in the EU or in a country with which Ireland has a tax treaty; and (b) a minimum 5% shareholding must have been held for a continuous period of at least 12 months within the previous 24 months.

There are broad exemptions from Irish withholding taxes on dividends, interest and royalties, including exemptions for payments to persons resident in tax treaty countries (and additionally, in the case of dividend payments, to companies controlled by persons resident in tax treaty countries).

Ireland has no controlled foreign company ("CFC") rules and no general thin capitalisation rules.

In terms of transaction tax costs, this can depend on how the investment is structured. Where the target is an Irish incorporated company, an Irish stamp duty cost will generally arise upon the acquisition, at a rate of 1% on the consideration paid (or market value, if higher), depending on how the investment is structured. For certain real estate holding companies, the stamp duty rate can be higher.

In terms of share acquisitions generally, appropriately structured, an interest deduction should be available for interest paid by an Irish holding company in connection with an acquisition of shares (subject to certain conditions being satisfied). Provided certain conditions are met, this tax deduction can be offset against the profits of the Irish target group. Appropriately structured, Irish withholding tax on the payment of interest can be reduced or eliminated.

As alluded to above, Ireland is also an attractive holding company location for PE investments outside Ireland.

Finally, Ireland has a beneficial tax regime applying to Irish domiciled investment funds (which can provide an attractive holding structure for PE investors).

Ireland is widely recognised as one of the world's most advantageous jurisdictions in which to establish investment funds. Our investment funds offering was bolstered in 2015 by the introduction of the Irish Collective Asset-management Vehicle ("ICAV"). The ICAV is a corporate entity that is able to elect its classification under the US "check the box" tax rules. Irish domiciled funds have a variety of attractive tax attributes, in particular that income and gains can accumulate free of Irish tax within the fund and that returns can be paid to non-Irish investors free of Irish tax provided certain declarations are in place. The ICAV has great potential in the context of PE transactions.

As regards whether offshore structures are common, in short, it depends. Given the attractive features of Ireland's holding company regime as set out above, Irish structures often feature. However, that said, we do see offshore structures used from time to time, the choice of structure depending on the factors set out in the first paragraph above.

9.2 What are the key tax-efficient arrangements that are typically considered by management teams in private equity acquisitions (such as growth shares, incentive shares, deferred / vesting arrangements)?

In general, whilst share incentivisation is common in Ireland, the tax treatment of most forms of share incentivisation is not particularly advantageous for employees/directors based in Ireland, with marginal rates of income tax, universal social charge and social security generally applying on any benefits obtained (subject to the comments below). However, if the shares that the employees receive qualify as "restricted shares" (under Irish tax rules), there could be a material abatement of up to 60% of the taxable value of the shares for Irish tax purposes (subject to certain qualifying conditions being met). This is, potentially, very favourable for employees/directors. Ireland has also introduced a "Key Employee Engagement Programme" ("KEEP") which provides for an exemption from income tax, universal social charge and social security arising on the exercise of a qualifying share option to acquire shares in a qualifying company in the SME sector provided certain conditions are satisfied.

Ireland has a specific tax regime for the return (known as "carried interest") received by venture capital managers for managing investments in certain venture capital funds. The regime operates by treating certain carried interest received by a partnership or a company as being subject to chargeable gains and applying a reduced rate to such carried interest. The share of profits which benefit from the reduced rate must relate to an investment in a trading company, which remains in place for at least six years and carries on qualifying "research and development" or "innovation activities", and satisfies certain additional conditions.

9.3 What are the key tax considerations for management teams that are selling and/or rolling-over part of their investment into a new acquisition structure?

A key tax consideration for management teams based in Ireland will be to ensure that any shares acquired as part of a roll-over will consist of an investment acquired in their capacity as a shareholder in the target or acquisition structure, and not in their capacity as an employee (and be documented as such), in order (as appropriate) to avail of CGT rates on the return on the investment (and not the marginal rates of income tax, universal social charge and social security).

Management teams will also be keen to ensure that "share-for-share" CGT relief will be available (where preferable) in order to defer any potential CGT in respect of the disposal of their holding in the target.

Stamp duty roll-over relief may also be relevant in the context of Irish target companies.

On an ongoing basis, the potential to avail of employee incentives such as the special assignee relief programme ("SARP"), and the foreign earnings deduction ("FED"), and any tax reliefs in the context of share awards will also be relevant.

9.4 Have there been any significant changes in tax legislation or the practices of tax authorities (including in relation to tax rulings or clearances) impacting private equity investors, management teams or private equity transactions and are any anticipated?

The ongoing implementation of the Anti-Tax Avoidance Directive ("ATAD") rules over the coming years in Ireland will require ongoing consideration in the context of PE investments.

Under Council Directive (EU) 2015/2376, Member States are required to exchange tax rulings issued in respect of certain "cross-border transactions" on a quarterly basis. This took effect in Ireland from 1 January 2017. In addition, Irish Revenue have issued new guidance on the validity period of opinions/confirmations issued by Irish Revenue, which are stated to be subject to a maximum validity period of five years, or such shorter period as may have been specified by Irish Revenue when providing the opinion/confirmation.


10.1 Have there been any significant legal and/or regulatory developments over recent years impacting private equity investors or transactions and are any anticipated?

The AIFMD has resulted in PE funds which operate in the EU becoming subject to additional regulation. In relation to PE transactions, the new regulation imposes new disclosure requirements in relation to portfolio companies and new restrictions on the ability of PE fund buyers to release assets from portfolio companies (the so-called "asset-stripping" rules). These obligations apply to all PE funds that are managed within the EU and also any PE funds that are marketed to investors in EU Member States pursuant to the AIFMD private placement regimes.

There is a requirement on an Irish body corporate or other legal entity to maintain its own register of beneficial owners. This register will list the individuals who ultimately own or control a legal entity through direct or indirect ownership of more than 25% of the shares or voting rights or ownership interest in that entity. Secondary legislation to formally establish a central beneficial ownership register to meet Ireland's obligations under the EU Fourth and Fifth Anti-Money Laundering Directives, has now also been signed into law. In addition to the requirement to have its own register of beneficial owners, from 22 June 2019 certain information must also be filed on a central register. Companies will have a period of five months from 22 June 2019 to make their first filings at the central register. In terms of access to information filed on the central register, the public may access it but access will be restricted to certain content only and it should be noted that personal identifier numbers and residential addresses will not be made available to the public. Competent Authorities such as the police and financial intelligence units will have wider access.

From 1 January 2019, only mergers where the acquirer and target each generate €10 million (or more) and together generate €60 million (or more) of turnover in Ireland will trigger mandatory notification in Ireland. The previous thresholds were €3 million and €50 million, respectively.

10.2 Are private equity investors or particular transactions subject to enhanced regulatory scrutiny in your jurisdiction (e.g. on national security grounds)?

Some sectors have special rules. In particular, if the transaction relates to the purchase of a business regulated by the Central Bank of Ireland ("CBI"), the proposed PE investors cannot acquire a qualifying holding in the regulated firm without first notifying the CBI and obtaining the pre-approval before the acquisition can take place. A "qualifying holding" is either a direct or indirect holding in a regulated firm that represents 10% or more of the capital of, or the voting rights in, the firm, or that makes it possible to exercise a significant influence over the management of that firm. Media mergers are subject to approval of the CCPC and the Minister for Communications, Climate Action and Environment and Irish airlines are subject to foreign control restrictions.

10.3 How detailed is the legal due diligence (including compliance) conducted by private equity investors prior to any acquisitions (e.g. typical timeframes, materiality, scope etc.)?

The level of legal due diligence will vary from transaction to transaction. Typically, diligence will be conducted over a three to six-week period. Materiality thresholds will vary from sector to sector but in a business with a small number of key contracts, a PE buyer may set no materiality threshold on those key contracts.

10.4 Has anti-bribery or anti-corruption legislation impacted private equity investment and/or investors' approach to private equity transactions (e.g. diligence, contractual protection, etc.)?

PE sellers are increasingly concerned with compliance with anti-corruption/bribery legislation principles, particularly given increasing regulatory scrutiny of corporate conduct and potentially significant financial penalties and reputational damage resulting from non-compliance. Typically, this concern is addressed by warranty protection regarding compliance with such laws.

The Criminal Justice (Corruption Offences) Act 2018 was enacted in 2018. This introduces a new corporate liability offence which allows for a corporate body to be held liable for the corrupt actions committed for its benefit by any director, manager, secretary, employee, agent or subsidiary. The single defence available to corporates for this offence is demonstrating that the company took "all reasonable steps and exercised all due diligence" to avoid the offence being committed.

10.5 Are there any circumstances in which: (i) a private equity investor may be held liable for the liabilities of the underlying portfolio companies (including due to breach of applicable laws by the portfolio companies); and (ii) one portfolio company may be held liable for the liabilities of another portfolio company?

Generally, an Irish court will not "pierce the corporate veil" so as to impose liability on a shareholder for the underlying activities/ liabilities of its subsidiary/investee company, provided the portfolio company is a limited liability company. If an unlimited company or partnership is used, its shareholders/partners can be liable for the entity's debts.


11.1 What other factors commonly give rise to concerns for private equity investors in your jurisdiction or should such investors otherwise be aware of in considering an investment in your jurisdiction?

Ireland provides an economically attractive venue for PE investment and PE industry. There are attractive tax structuring options for non-Irish PE investors (e.g. the ICAV structure). See section 9 above.

First published by the International Comparative Legal Guide to: Private Equity 2019.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions